Ad is loading...
MENU
OCUL
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Ocular Therapeutix (OCUL) Ownership - Who owns Ocular Therapeutix?
Industry: @Pharmaceuticals Other
Profile
Industry
Pharmaceuticals Other
Address
15 Crosby Drive
Phone
+1 781 357-4000
Employees
267
Web
https://www.ocutx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.38B
P/E Ratio
N/A
Total Cash
427.22M
Projected Growth
N/A
Total Debt
75.12M
Revenue
61.44M
Risk (Beta)
1.45
Dividend Yield
N/A
Total Cash/Share
2.72
Total Debt/Equity
N/A
Revenue/Share
0.44 USD as % of share price
Fundamentals
OCUL
Capitalization
1.38B
P/E Ratio
N/A
Risk (Beta)
1.45
Dividend Yield
N/A
Total Cash
427M
Total Cash/Share
2.72
Total Debt
75.1M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.44%
Revenue
61.4M
ROE
N/A
Book Value
352M
P/B Ratio
3.81
Cash Flow
N/A
Earnings
-1.29
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
16K
Current Ratio
13.01
Current Revenue Per Employee
57771.54
Dividends Per Share - Security
N/A
EBITDA
-155.92M
Float
N/A
Float - Current
N/A
Gross Income Margin
89.88
Revenue To Assets
-53.42
Shares Held By Institutions
1.38B
Shares Outstanding - Current
157M
Total Liabilities
138M
Total Volume MTD
N/A
Value
N/A
Gain YTD
91.031
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of therapies for diseases and conditions of the eye using its proprietary hydrogel platform technology
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
15 Crosby Drive
Phone
+1 781 357-4000
Employees
267
Web
https://www.ocutx.com